How to defuse a demographic time bomb: the way forward?

[1]  B. Foot,et al.  Surveillance of sight loss due to delay in ophthalmic treatment or review: frequency, cause and outcome , 2017, Eye.

[2]  S. Coronini-Cronberg,et al.  The Royal College of Ophthalmologists' Cataract Surgery Commissioning Guidance: executive summary , 2016, Eye.

[3]  Richard C. Lin,et al.  Barriers to Follow-Up and Strategies to Improve Adherence to Appointments for Care of Chronic Eye Diseases. , 2015, Investigative ophthalmology & visual science.

[4]  Wide-field imaging and OCT vs clinical evaluation of patients referred from diabetic retinopathy screening , 2015, Eye.

[5]  D. Flanagan,et al.  Implementation of a nurse-delivered intravitreal injection service , 2014, Eye.

[6]  Is it safe to discharge treated proliferative diabetic retinopathy patients from the hospital eye service to a community screening programme? , 2014, Eye.

[7]  J. Olson,et al.  Rates of referable eye disease in the Scottish National Diabetic Retinopathy Screening Programme , 2014, British Journal of Ophthalmology.

[8]  W. Rathmann,et al.  Projection of the burden of Type 2 diabetes mellitus in Germany: a demographic modelling approach to estimate the direct medical excess costs from 2010 to 2040 , 2013, Diabetic medicine : a journal of the British Diabetic Association.

[9]  P. Khaw,et al.  The effectiveness of schemes that refine referrals between primary and secondary care—the UK experience with glaucoma referrals: the Health Innovation & Education Cluster (HIEC) Glaucoma Pathways Project , 2013, BMJ Open.

[10]  H. Lemij,et al.  Why a successful task substitution in glaucoma care could not be transferred from a hospital setting to a primary care setting: a qualitative study , 2013, Implementation Science.

[11]  A. Darzi,et al.  Evaluation of clinical threshold policies for cataract surgery among English commissioners , 2012, Journal of health services research & policy.

[12]  Benjamin D. Hennig,et al.  The global inverse care law: a distorted map of blindness , 2012, British Journal of Ophthalmology.

[13]  S. Resnikoff,et al.  The number of ophthalmologists in practice and training worldwide: a growing gap despite more than 200 000 practitioners , 2012, British Journal of Ophthalmology.

[14]  Action on AMD. Optimising patient management: act now to ensure current and continual delivery of best possible patient care , 2012, Eye.

[15]  Action on AMD. Optimising patient management: act now to ensure current and continual delivery of best possible patient care , 2012, Eye.

[16]  D. O'Sullivan,et al.  The Carmarthenshire Glaucoma Referral Refinement Scheme, a safe and efficient screening service , 2011, Eye.

[17]  M. Hingorani,et al.  Can a community optometrist-based referral refinement scheme reduce false-positive glaucoma hospital referrals without compromising quality of care? The community and hospital allied network glaucoma evaluation scheme (CHANGES) , 2010, Eye.

[18]  S. Vernon,et al.  Shared care in glaucoma: a national study of secondary care lead schemes in England , 2010, Eye.

[19]  Michael O'Grady,et al.  Projecting the Future Diabetes Population Size and Related Costs for the U.S. , 2009, Diabetes Care.

[20]  J. Olson,et al.  The efficacy of automated “disease/no disease” grading for diabetic retinopathy in a systematic screening programme , 2007, British Journal of Ophthalmology.

[21]  D. Henson,et al.  Community refinement of glaucoma referrals , 2003, Eye.

[22]  T. Peters,et al.  The Bristol Shared Care Glaucoma Study: reliability of community optometric and hospital eye service test measures , 1999, The British journal of ophthalmology.

[23]  Comparing Costs of Monitoring Glaucoma Patients: Hospital Ophthalmologists versus Community Optometrists , 1997, Journal of health services research & policy.